Filing Details
- Accession Number:
- 0001415889-23-003908
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-02 19:36:37
- Reporting Period:
- 2023-02-28
- Accepted Time:
- 2023-03-02 19:36:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1778075 | F John Ginascol | 100 Abbott Park Road Abbott Park IL 60064 | Executive Vice President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Disposition | 2023-02-28 | 6,859 | $99.77 | 119,323 | No | 4 | F | Direct | |
| Common Shares Without Par Value | Disposition | 2023-03-01 | 943 | $100.70 | 118,380 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
